Saso Cemerski
Executive Director & Head of Immune Engagers AstraZeneca
Dr. Saso Cemerski is Executive Director and Head of Immune Engagers at AstraZeneca. With a background spanning immunology, oncology, and biologics engineering, he previously held scientific leadership roles at Cue Biopharma, Merck Research Labs, and Bristol‑Myers Squibb. Dr. Cemerski completed his PhD in Immunology at Université Paul Sabatier and conducted postdoctoral research at Washington University School of Medicine.
Seminars
Wednesday 24th June 2026
Panel Discussion: Reflecting on Past Successes & Future Challenges Across the T-Cell Engager Landscape to Assess the Benchmark for Success & Accelerate TCEs to Patients
8:30 am
- Reflecting on the move away from first generation BiTE molecules to next-generation logic-gated and multi-specific T cell engagers
- Exploring advancements in preclinical and clinical modelling of TCEs to allow for improvements in efficacy whilst minimizing system toxicity
- Evaluating the potential for TCEs to serve as a scalable, off-the-shelf alternative to personalized CAR-T therapies
Wednesday 24th June 2026
Novel Immune Cell Engagers for Cancer
9:30 am
- Exploring strategies for widening the therapeutic index in solid tumors and haematological malignancies
- Development of CD8-biased T cell engagers
- Supporting T cell mediated anti-tumor immunity with CD8-biased IL-2
